Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases

Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases

BackgroundOur previous study suggested CD36 may be a positive regulator of hepatitis B virus (HBV) replication in vitro. Therefore, the present study aimed to investigate whether circulating soluble CD36 (sCD36) could serve as a diagnostic and prognostic biomarker for HBV-related liver diseases base...

Full description

Bibliographic Details
Main Authors: Chunxian Cai, Anhua Xiao, Xiaoqing Luo, Enze Zheng, Yiyu Li, Yu Lei, Shan Zhong, Yaxi Chen, Ping Yang, Zhurong Tang, Zhi Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Microbiology
Subjects:
sCD36
biomarker
HBV-related liver diseases
cirrhosis
liver failure
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.1039614/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2022.1039614/full

Similar Items